The Dialysis Catheters industry trends have seen significant momentum over the past 18 months, driven by innovation in antimicrobial technologies and expanding home dialysis adoption. Strategic partnerships have accelerated, with Fresenius Medical Care collaborating with Medtronic in 2023 to co-develop smart catheters with real-time infection monitoring. On the Mergers & acquisitions front, Bard Peripheral Vascular acquired BioSure in late 2023, securing proprietary antimicrobial coating technology to reduce catheter-related bloodstream infections. Product launches highlight advancements: B. Braun launched the SafeCath Pro in 2024, featuring enhanced biocompatibility and reduced thrombosis risk. Regulatory changes in 2024, including the FDAโs updated guidance on catheter safety standards, have pushed manufacturers to prioritize design durability and patient comfort. Meanwhile, enterprise trends reflect a shift toward value-based care, with hospitals prioritizing cost-effective, long-term catheter solutions. Funding rounds surged in 2023โ2024, with startups like Nephros securing $45M in Series B funding to scale AI-driven catheter placement systems, signaling a tech-driven future for the industry.